CLINICAL_TRIALS
trial_result
· 2015-09-09
Clinical Trial Update: Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye [Phase 2]
Summary
Phase 2 study of cis-UCA ophthalmic solution for dry eye syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Herantis Pharma Plc. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED